Improvements in Intractable Lumbar and LowerExtremity Symptoms after Systemic Administration of Tocilizumab, an Anti-interleukin-6 Receptor Antibody
Takeshi Sainoh, Sumihisa Orita, Masayuki Miyagi, Miyako Suzuki-Narita, Yoshihiro Sakuma, Yasuhiro Oikawa, Go Kubota, Jun Sato, Yasuhiro Shiga, Kazuki Fujimoto, Yawara Eguchi, Masao Koda, Yasuchika Aoki, Tsutomu Akazawa, Takeo Furuya, Junichi Nakamura, Hiroshi Takahashi, Satoshi Maki, Masahiro Inoue, Hideyuki Kinoshita, Masaki Norimoto, Takashi Sato, Masashi Sato, Masahiro Suzuki, Keigo Enomoto, Hiromitsu Takaoka, Norichika Mizuki, Takashi Hozumi, Ryuto Tsuchiya, Geundong Kim, Takuma Otagiri, Tomohito Mukaihata, Takahisa Hishiya, Seiji Ohtori, Kazuhide Inage
Asian Spine J. 2022;16(1):99-106.   Published online 2021 May 21     DOI: https://doi.org/10.31616/asj.2020.0283
Citations to this article as recorded by Crossref logo
The association between inflammatory biomarkers and low back disorder: a systematic review and meta-analysis
Stone Sima, Xiaolong Chen, Ashish D. Diwan
Biomarkers.2024; : 1.     CrossRef
The Role of Neuro-Immune Interactions in Chronic Pain: Implications for Clinical Practice
Po-Yi Paul Su, Lingyi Zhang, Liangliang He, Na Zhao, Zhonghui Guan
Journal of Pain Research.2022; Volume 15: 2223.     CrossRef